Financial relations between leaders of US medical societies and industryBMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1811 (Published 27 May 2020) Cite this as: BMJ 2020;369:m1811
- Jake Checketts, resident orthopedic surgeon12,
- Matt Vassar, clinical assistant professor2
- 1Department of Orthopedic Surgery, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, US
- 2Department of Psychiatry, Oklahoma State University Center for Health Sciences, US
- Correspondence to: J Checketts
The Sunshine Act was passed as a part of the Affordable Care Act in 2010 in the hopes of shedding light on relationships between physicians and industry in the US.1 This enactment resulted in the creation of the Open Payments database, which reports the financial benefits paid to physicians from April 2013 up to present time.2 These data have resulted in numerous studies evaluating financial ties of individual physicians,34 those of guideline authors,567 and those of doctors conducting randomized controlled trials89—ties that could unduly influence medical practice and research. Until now, however, we have lacked information on the extent of financial conflicts of interest among leaders of national medical associations and societies.
In the linked study, Moynihan and colleagues …